NCT06511076View on ClinicalTrials.gov

A Study to Evaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

November 26, 2024

Study Completion Date

November 26, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

Zilucoplan

Participants will receive a single sc injection of zilucoplan in the pre-specified sequence.

Trial Locations (1)

Unknown

DV0012 1, Groningen

All Listed Sponsors

lead

UCB Biopharma SRL

INDUSTRY

NCT06511076 - A Study to Evaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in Healthy Adult Participants | Biotech Hunter | Biotech Hunter